| Literature DB >> 35529955 |
Abida Ashraf1,2, Muhammad Khalid3, Muhammad Nawaz Tahir4, Muhammad Yaqub1, Muhammad Moazzam Naseer5, Ghulam Mustafa Kamal3, Bullo Saifullah3,6, Ataualpa Albert Carmo Braga7, Zahid Shafiq1, Waqar Rauf8.
Abstract
In this work, we report the efficient synthesis of novel (hydroxybenzoyl)pyrido[2,3-d]pyrimidine heterocycle derivatives: 6-(2-hydroxy-5-methylbenzoyl)-1-methylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione (6a), 6-(5-fluoro-2-hydroxybenzoyl)-1-methylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione (6b), 6-(5-ethyl-2-hydroxybenzoyl)-1-methylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione (6c) and 6-(2-hydroxy-5-isopropylbenzoyl)-1-methylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione (6d). The chemical structures of the title compounds were ascertained by spectral techniques including 1H, 13C NMR, UV-visible and FT-IR spectroscopy as well as single-crystal X-ray diffraction analysis. Additionally, density functional theory (DFT) and time-dependent (TD-DFT) computation were adopted to analyze the electronic structures of 6a-d. Compounds 6a-d were computed in the ground state for FT-IR spectroscopic and natural bond orbital (NBO) analysis by DFT/B3LYP with the 6-311+G(d,p) basis set. UV-vis spectroscopic and HOMO and LUMO energy values for 6a-d were determined via TD-DFT/B3LYP with the 6-311+G(d,p) basis set. The optimized geometric parameters, UV-vis findings, and vibrational frequencies indicate good consistency with the experimental data. NBO analysis was conducted to explore the interactions and charge transfer among different orbitals in the title compounds. The HOMO and LUMO band gap (ΔE) values for 6a-d were found to be 3.93, 3.91, 4.10 and 3.91 eV, respectively. Molecular electrostatic potential (MEP) analysis explored the reactivity of the title compounds by predicting their nucleophilic as well as electrophilic sites. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35529955 PMCID: PMC9073913 DOI: 10.1039/c9ra05415d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Some drugs with a pyridopyrimidine skeleton.
Scheme 1The synthesis of the pyrido[2,3-d]pyrimidine derivatives 6a–d.
X-ray crystallographic data for 6a–d
| Crystal data | 6a | 6b | 6c | 6d |
|---|---|---|---|---|
| CCDC |
|
|
|
|
| Chemical formula | C16H13N3O4 | C15H10FN3O4 | C17H15N3O4 | C18H17N3O4 |
|
| 311.29 | 315.26 | 325.32 | 339.34 |
| Crystal system, space group | Monoclinic, | Monoclinic, | Monoclinic, | Triclinic, |
| Temperature (K) | 296 | 296 | 296 | 296 |
|
| 8.1712 (11), 13.873 (2), 12.3934 (17) | 23.336 (3), 6.9240 (6), 17.2853 (18) | 11.7250 (5), 13.3565 (6), 10.1992 (4) | 8.4030 (4), 9.6898 (4), 10.9110 (7) |
|
| 92.098 (6) | 108.798 (3) | 114.332 (2) | 105.870 (2), 98.586 (2), 102.351 (4) |
|
| 1403.9 (3) | 2643.9 (5) | 1455.37 (11) | 814.10 (7) |
|
| 4 | 8 | 4 | 2 |
| Radiation type | Mo Kα | Mo Kα | Mo Kα | Mo Kα |
|
| 0.11 | 0.13 | 0.11 | 0.10 |
| Crystal size (mm) | 0.44 × 0.30 × 0.28 | 0.44 × 0.38 × 0.30 | 0.44 × 0.38 × 0.36 | 0.41 × 0.30 × 0.27 |
|
| ||||
|
| 0.940, 0.980 | 0.930, 0.970 | 0.930, 0.975 | 0.940, 0.985 |
| No. of measured, independent and observed [ | 9802, 3315, 2477 | 8315, 3120, 2521 | 8838, 3413, 2687 | 8321, 3154, 2336 |
|
| 0.057 | 0.031 | 0.035 | 0.032 |
| (sin | 0.659 | 0.658 | 0.659 | 0.617 |
|
| ||||
|
| 0.055, 0.172, 1.04 | 0.043, 0.123, 1.04 | 0.046, 0.133, 1.05 | 0.048, 0.156, 1.04 |
| Δ〉max, Δ〉min (e Å−3) | 0.38, −0.28 | 0.26, −0.19 | 0.29, −0.20 | 0.23, −0.23 |
Fig. 2The molecular structures (ORTEP diagram) of 6-(2-hydroxybenzoyl)-1-methylpyridopyrimidine-2,4-diones 6a–d. Displacement ellipsoids are drawn at the 50% probability level.
Fig. 3The hydrogen bond-driven supramolecular chains in 6a–d.
Fig. 43D packing of (a) 6a along the c-axis; (b) 6c along the b-axis; (c) 6d along the a-axis; and (d) 6b along the b-axis in the solid state.
Fig. 5Frontier molecular orbitals of 6a.
Fig. 6Frontier molecular orbitals of 6b.
Fig. 7Frontier molecular orbitals of 6c.
Fig. 8Frontier molecular orbitals of 6d.
Computed energies (E) for compounds 6a–da
| 6a | 6b | 6c | 6d | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MO | Energy | Δ | MO | Energy | Δ | MO | Energy | Δ | MO | Energy | Δ |
| HOMO | −6.6 | 3.93 | HOMO | −6.8 | 3.91 | HOMO | −10.6 | 4.10 | HOMO | −6.5 | 3.91 |
| LUMO | −2.6 | LUMO | −2.9 | LUMO | −6.5 | LUMO | −2.6 | ||||
| HOMO−1 | −7.2 | 4.8 | HOMO−1 | −7.3 | 4.7 | HOMO−1 | −10.7 | 5.10 | HOMO−1 | −7.2 | 4.78 |
| LUMO+1 | −2.4 | LUMO+1 | −2.5 | LUMO+1 | −5.6 | LUMO+1 | −2.4 | ||||
| HOMO−2 | −7.7 | 6.23 | HOMO−2 | −7.9 | 6.24 | HOMO−2 | −11.2 | 6.10 | HOMO−2 | −7.6 | 6.291 |
| LUMO+2 | −1.5 | LUMO+2 | −1.7 | LUMO+2 | −5.2 | LUMO+2 | −1.4 | ||||
E = energy; ΔE (eV) = ELUMO − EHOMO; HOMO, highest occupied molecular orbital; LUMO, lowest unoccupied molecular orbital; MO, molecular orbital.
Ionization potential (I), electron affinity (A), electronegativity (X), global hardness (η), chemical potential (μ), global electrophilicity (ω), electron donor capability (ω−), electron acceptor capability (ω+) and global softness (σ) values of 6a–d (units in eV)
| Com |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| 6a | 4.80 | 4.43 | 4.62 | 0.18 | −4.62 | 57.42 | 59.75 | 55.13 | 2.69 |
| 6b | 5.46 | 4.63 | 5.04 | 0.41 | −5.04 | 30.79 | 33.36 | 28.32 | 1.21 |
| 6c | 5.20 | 4.43 | 4.81 | 0.38 | −4.81 | 30.09 | 32.55 | 27.73 | 1.30 |
| 6d | 5.14 | 4.43 | 4.78 | 0.35 | −4.78 | 32.16 | 34.59 | 29.81 | 1.41 |
Wavelengths, excitation energies, and oscillator strengths for 6a–da
| Com | Exp | DFT |
|
| MO contributions |
|---|---|---|---|---|---|
| 6a | 364 | 27 437 | 0.1408 | H → L (97%) | |
| 332 | 342 | 29 193 | 0.0017 | H → L+1 (99%) | |
| 327 | 30 522 | 0.0131 | H-4 → L (27%), H-3 → L (29%), H-2 → L (15%), H-1 → L (23%) | ||
| 305 | 302 | 33 156 | 0.2089 | H-1 → L (52%), H-1 → L+1 (27%), H-4 → L (4%), H-3 → L (3%), H-3 → L+1 (3%), H-2 → L (6%) | |
| 300 | 294 | 34 030 | 0.0761 | H-4 → L+1 (10%), H-3 → L+1 (33%), H-1 → L (13%), H-1 → L+1 (24%), H-3 → LUMO (4%), H-2 → L (9%), H-2 → L+1 (2%) | |
| 292 | 34 260 | 0.0399 | H-4 → L+1 (10%), H-3 → L+1 (29%), H-1 → L+1 (39%), H-4 → L (4%), H-2 → L (4%), H-1 → L (6%) | ||
| 6b | 377 | 367 | 27 245 | 0.1553 | H → L (97%) |
| 373 | 336 | 29 736 | 0.002 | H → L+1 (98%) | |
| 300 | 330 | 30 331 | 0.0282 | H-4 → L (25%), H-3 → L (20%), H-2 → L (15%), H-1 → L (33%), H-6 → L (2%) | |
| 307 | 32 606 | 0.1772 | H-3 → L (14%), H-2 → L (18%), H-1 → L (60%), H-4 → L (5%) | ||
| 298 | 33 599 | 0.0738 | H-1 → L+1 (93%) H-8 → L (2%) | ||
| 293 | 34 114 | 0.0043 | H-2 → L+1 (85%) H-3 → L+1 (3%) | ||
| 6c | 332 | 367 | 27 347 | 0.1357 | H → L (97%) |
| 311 | 343 | 29 155 | 0.0018 | H → L+1 (99%) | |
| 305 | 328 | 30 511 | 0.0131 | H-4 → L (26%), H-3 → L (33%), H-2 → L (13%), H-1 → L (22%) | |
| 6d | 372 | 368.198 | 27 159 | 0.120 | H → L (96%) |
| 365 | 350.274 | 28 549 | 0.002 | H → L+1 (98%) | |
| 313 | 327.391 | 30 544 | 0.019 | H-4 → L (20%), H-3 → L (38%), H-1 → L (28%), H-2 → L (8%) | |
| 298.863 | 33 460 | 0.125 | H-3 → L (10%), H-1 → L (45%), H-1 → L+1 (35%), H-2 → L (4%) | ||
| 298.517 | 33 499 | 0.195 | H-2 → L (12%), H-1 → L (20%), H-1 → L+1 (55%), H-3 → L (7%) | ||
| 292.103 | 34 234 | 0.008 | H-4 → L+1 (25%), H-3 → L+1 (61%), H-4 → L (3%) |
Com = compounds; Exp = experimental; E = Excitation energy; λ = wavelength; f = oscillator strength; MO = molecular orbitals; H = HOMO; L = LUMO; λ (nm).
Acetone.
DMSO.
1,4-Dioxane.